secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-07-10T21:10:14+00:00
Accession:  0001213900-26-077250
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX cancels 1.01M shares to comply with NYSE American stockholder approval rule
--------------------------------------------------------------------------------

- 1,013,637 restricted shares issued on June 2, 2026 upon conversion of $379,000 promissory note under a line of credit.
- NYSE American determined the acquisition and line of credit are related transactions requiring shareholder approval under Section 712.
- All 1,013,637 shares were cancelled on July 10, 2026 and returned to treasury to regain compliance.
- Company will seek stockholder approval at a future meeting; no assurance of obtaining approval.
- Failure to obtain approval could lead to further NYSE American action regarding listing of PHGE common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026077250/0001213900-26-077250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026077250/ea0297633-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-077250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer